Coronavirus Disease-19

Baird, Brandon J.; Sung, C. Kwang

doi:10.1016/j.otc.2020.08.004

Cited by 5 publications

(3 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a survey evaluating the acceptability of telemedicine in oral and maxillofacial surgery in the UK, patients were found to be mostly happy with telemedicine [58]. However, inability to inspect cavities due to poor lighting during the telemedicine encounters [59, 60] was reported as one of the challenges.…”

Section: Resultsmentioning

confidence: 99%

The Role of Telemedicine in Surgical Specialties During the COVID‐19 Pandemic: A Scoping Review

et al. 2021

View full text Add to dashboard Cite

Background The objective of this study was to evaluate the current body of evidence on the use of telemedicine in surgical subspecialties during the COVID‐19 pandemic. Methods This was a scoping review conducted in compliance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for scoping reviews (PRISMA‐ScR). MEDLINE via Ovid, PubMed, and EMBASE were systematically searched for any reports discussing telemedicine use in surgery and surgical specialties during the first period (February 2020–August 8, 2020) and second 6‐month period (August 9–March 4, 2021) of the COVID‐19 pandemic. Results Of 466 articles screened through full text, 277 articles were included for possible qualitative and/or quantitative data synthesis. The majority of publications in the first 6 months were in orthopedic surgery, followed by general surgery and neurosurgery, whereas in the second 6 months of COVID‐19 pandemic, urology and neurosurgery were the most productive, followed by transplant and plastic surgery. Most publications in the first 6 months were opinion papers (80%), which decreased to 33% in the second 6 months. The role of telemedicine in different aspects of surgical care and surgical education was summarized stratifying by specialty. Conclusion Telemedicine has increased access to care of surgical patients during the COVID‐19 pandemic, but whether this practice will continue post‐pandemic remains unknown.

show abstract

Section: Resultsmentioning

confidence: 99%

The Role of Telemedicine in Surgical Specialties During the COVID‐19 Pandemic: A Scoping Review

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Several groups developed recommendations on the management of patients with head and neck cancer during the pandemic, including both general recommendations as well as specific surgical and non-surgical recommendations [16][17][18][19][20] . Treatment of head and neck cancer has been restricted around the world due to capacity limitations and to the increased risk of infection for both staff and patients.…”

Section: Type Of Treatmentmentioning

confidence: 99%

The impact of the Covid-19 pandemic on the management of head and neck cancer patients at a tertiary care institution in Poland: A case-control study

Szewczyk,

Pazdrowski,

Golusiński

et al. 2024

Preprint

View full text Add to dashboard Cite

Objective: To assess the impact of the Covid-19 pandemic on the diagnosis and treatment of patients at tertiary hospital in Poland. Design, setting, participants: This was a retrospective review of head and neck cancer patients presented to the multidisciplinary tumour board (MTB) during the 12-month period from March 2020 through February 2021 and compared to patients presented to the MTB during the prior, pre-pandemic 12-month period from February 2019 to March 2020. Main outcomes and measures: Patient demographic and clinical variables were compared: sex; age at diagnosis; distance from hospital; date of first visit, radiological diagnosis, pathology specimen, MTB meeting, and initiation of primary and adjuvant treatment Results: The number of patients presented to the MTB increased by 22% (278 to 340) from the pre-pandemic to the pandemic period. The mean time from MTB presentation to treatment initiation increased significantly from 17.1 to 21.7 days. The mean time from first visit to treatment start increased from 44.7 to 54.4 days. The proportion of patients with early-stage oropharyngeal cancer who underwent primary surgery rose from 47.3% to 86.6%. The percentage of patients who received palliative radiotherapy increased from 20.5% to 32.9%. The proportion of patients who received best supportive care rose from 1.8% to 6.2%. Conclusion: One of the most notable findings of this study was the increased time from first visit to treatment initiation, which could negatively impact patient outcomes. The differences in the treatment received in these two periods should be further evaluated to determine their influence on survival

show abstract

“…Several groups developed recommendations on the management of patients with head and neck cancer during the pandemic, including general recommendations as well as specific surgical and non-surgical recommendations [16][17][18][19][20]. Treatment of head and neck cancer has been restricted around the world due to capacity limitations and to the increased risk of infection for both staff and patients.…”

Section: Type Of Treatmentmentioning

confidence: 99%

The impact of the COVID-19 pandemic on the management of head and neck cancer patients at a tertiary care institution in Poland

Szewczyk¹,

Pazdrowski²,

Golusiński³

et al. 2021

View full text Add to dashboard Cite

Aim of the study: To assess the impact of the COVID-19 pandemic on the diagnosis and treatment of patients at a tertiary hospital in Poland. Material and methods: This was a retrospective review of head and neck cancer patients who presented to the multidisciplinary tumour board (MTB) during the 12-month period from March 2020 to February 2021 and compared to patients who presented to the MTB during the prior, pre-pandemic 12-month period from February 2019 to March 2020: Patient demographic and clinical variables were compared: sex, age at diagnosis, distance from hospital, date of first visit, radiological diagnosis, pathology specimen, MTB meeting, and initiation of primary and adjuvant treatment Results: The number of patients who presented to the MTB increased by 22% (278 to 340) from the pre-pandemic to the pandemic period. The mean time from MTB presentation to treatment initiation increased significantly from 17.1 to 21.7 days. The mean time from first visit to treatment start increased from 44.7 to 54.4 days. The proportion of patients with early-stage oropharyngeal cancer who underwent primary surgery rose from 47.3% to 86.6%. The percentage of patients who received palliative radiotherapy increased from 20.5% to 32.9%. The proportion of patients who received best supportive care rose from 1.8% to 6.2%. Conclusions: One of the most notable findings of this study was the increased time from first visit to treatment initiation, which could negatively impact patient outcomes. The differences in the treatment received in these two periods should be further evaluated to determine their influence on survival.

show abstract

Coronavirus Disease-19

Cited by 5 publications

References 49 publications

The Role of Telemedicine in Surgical Specialties During the COVID‐19 Pandemic: A Scoping Review

The Role of Telemedicine in Surgical Specialties During the COVID‐19 Pandemic: A Scoping Review

The impact of the Covid-19 pandemic on the management of head and neck cancer patients at a tertiary care institution in Poland: A case-control study

The impact of the COVID-19 pandemic on the management of head and neck cancer patients at a tertiary care institution in Poland

Contact Info

Product

Resources

About